StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)

Close on Nov 17, 2026Market cap $48.11MP/E –Yield –

iBio total assets

Total assets on the balance sheet at the end of each period.

iBio's total assets was $88.65M at Sep 30, 2026. For fiscal 2026 it was $99.11M, up 327.5% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $146.97M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$99.11M+327.5%
FY2025Jun 30, 2025$23.19M-19.3%
FY2024Jun 30, 2024$28.73M-30.3%
FY2023Jun 30, 2023$41.21M-58.5%
FY2022Jun 30, 2022$99.41M-32.4%
FY2021Jun 30, 2021$146.97M+56.0%
FY2020Jun 30, 2020$94.19M+207.9%
FY2019Jun 30, 2019$30.59M-29.0%
FY2018Jun 30, 2018$43.08M+19.6%
FY2017Jun 30, 2017$36.01M-30.2%
FY2016Jun 30, 2016$51.60M+313.0%
FY2015Jun 30, 2015$12.49M+92.4%
FY2014Jun 30, 2014$6.49M-30.6%
FY2013Jun 30, 2013$9.35M-4.2%
FY2012Jun 30, 2012$9.77M+33.1%
FY2011Jun 30, 2011$7.34M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$88.65M+38.2%
Q4 FY2026CQ2 2026Jun 30, 2026$99.11M+327.5%
Q3 FY2026CQ1 2026Mar 31, 2026$85.83M+349.3%
Q2 FY2026CQ4 2025Dec 31, 2025$64.39M+196.8%
Q1 FY2026CQ3 2025Sep 30, 2025$64.16M+161.7%
Q4 FY2025CQ2 2025Jun 30, 2025$23.19M-19.3%
Q3 FY2025CQ1 2025Mar 31, 2025$19.10M-61.9%
Q2 FY2025CQ4 2024Dec 31, 2024$21.70M-36.2%
Q1 FY2025CQ3 2024Sep 30, 2024$24.52M-34.9%
Q4 FY2024CQ2 2024Jun 30, 2024$28.73M-30.3%
Q3 FY2024CQ1 2024Mar 31, 2024$50.15M+13.0%
Q2 FY2024CQ4 2023Dec 31, 2023$34.02M-34.3%
Q1 FY2024CQ3 2023Sep 30, 2023$37.68M-55.4%
Q4 FY2023CQ2 2023Jun 30, 2023$41.21M-58.5%
Q3 FY2023CQ1 2023Mar 31, 2023$44.39M-61.5%
Q2 FY2023CQ4 2022Dec 31, 2022$51.80M-59.0%
Q1 FY2023CQ3 2022Sep 30, 2022$84.56M-42.5%
Q4 FY2022CQ2 2022Jun 30, 2022$99.41M-30.3%
Q3 FY2022CQ1 2022Mar 31, 2022$115.37M-20.7%
Q2 FY2022CQ4 2021Dec 31, 2021$126.45M+7.8%
Q4 FY2021CQ2 2021Jun 30, 2021$146.97M+56.0%
Q3 FY2021CQ1 2021Mar 31, 2021$142.70M+238.0%
Q2 FY2021CQ4 2020Dec 31, 2020$145.41M+299.6%
Q1 FY2021CQ3 2020Sep 30, 2020$117.26M+233.5%
Q4 FY2020CQ2 2020Jun 30, 2020$94.19M+207.9%
Q3 FY2020CQ1 2020Mar 31, 2020$42.22M+18.3%
Q2 FY2020CQ4 2019Dec 31, 2019$36.38M-9.7%
Q1 FY2020CQ3 2019Sep 30, 2019$35.16M-18.0%
Q4 FY2019CQ2 2019Jun 30, 2019$30.59M-29.0%
Q3 FY2019CQ1 2019Mar 31, 2019$35.67M+15.0%
Q2 FY2019CQ4 2018Dec 31, 2018$40.30M+15.7%
Q1 FY2019CQ3 2018Sep 30, 2018$42.90M+28.3%
Q4 FY2018CQ2 2018Jun 30, 2018$43.08M+19.6%
Q3 FY2018CQ1 2018Mar 31, 2018$31.03M-23.7%
Q2 FY2018CQ4 2017Dec 31, 2017$34.84M-21.2%
Q1 FY2018CQ3 2017Sep 30, 2017$33.43M-30.5%
Q4 FY2017CQ2 2017Jun 30, 2017$36.01M–
Q3 FY2017CQ1 2017Mar 31, 2017$40.70M–
Q2 FY2017CQ4 2016Dec 31, 2016$44.19M–
Q1 FY2017CQ3 2016Sep 30, 2016$48.09M–

More iBio figures

See a number that looks wrong?